Unravelling Subjectivity, Embodied Experience and (taking) Psychotropic Medication

Overview

Journal Soc Sci Med

Date 2019 Apr 13

PMID 30978572

Citations 4

Authors

Jacinthe Flore

Renata Kokanovic

Felicity Callard

Alex Broom

Cameron Duff

Affiliations

Soon will be listed here.

Abstract

This paper explores how distinctions between 'intended' and 'side' effects are troubled in personal narratives of taking psychotropic medications. Grounded in interviews with 29 participants diagnosed with mental illness in Victoria, Australia between February and December 2014, we consider how people interpret pharmaceutical compounds beyond their desired or intended effects, and how such effects shape and transform subjectivity and their relationship with their bodies. This paper contributes to recent discussions of mental illness and medication effects, informed by feminist science studies. It emphasises the co-constitution of social, affective and material relations in the context of 'taking' psychotropic medication. This paper discusses three key themes as important to the phenomenology of the nexus of illness and psychotropic medication: movement, ambivalence, and sociality. Our analysis demonstrates how psychotropic drugs are productive of subjectivity through their promises and potential, their unexpected harms and the institutions from which they are inseparable.

Citing Articles

Pharmaceuticalization and Care Coordination in New York City Outpatient Mental Health.

Aggarwal N Med Anthropol. 2024; 43(5):383-396.

PMID: 39037498 PMC: 11306980. DOI: 10.1080/01459740.2024.2378092.

Critical qualitative research on 'madness': knowledge making and activism among those designated 'mad'.

Rose D Wellcome Open Res. 2021; 6:98.

PMID: 34368466 PMC: 8314133. DOI: 10.12688/wellcomeopenres.16711.1.

Gender Influences on Physical Activity Awareness of Adolescents and Their Parents.

Lago-Ballesteros J, Garcia-Pascual M, Gonzalez-Valeiro M, Fernandez-Villarino M Int J Environ Res Public Health. 2021; 18(11).

PMID: 34073409 PMC: 8198382. DOI: 10.3390/ijerph18115707.

(Re)shaping the self: An ethnographic study of the embodied and spatial practices of women who use drugs.

Collins A, Boyd J, Czechaczek S, Hayashi K, McNeil R Health Place. 2020; 63:102327.

PMID: 32224291 PMC: 7306434. DOI: 10.1016/j.healthplace.2020.102327.

References

Rose N . Beyond medicalisation. Lancet. 2007; 369(9562):700-2. DOI: 10.1016/S0140-6736(07)60319-5. View

Duff C . The social life of drugs. Int J Drug Policy. 2013; 24(3):167-72. DOI: 10.1016/j.drugpo.2012.12.009. View

McCann T, Clark E . Embodiment of severe and enduring mental illness: finding meaning in schizophrenia. Issues Ment Health Nurs. 2004; 25(8):783-98. DOI: 10.1080/01612840490506365. View

Carrick R, Mitchell A, Powell R, Lloyd K . The quest for well-being: a qualitative study of the experience of taking antipsychotic medication. Psychol Psychother. 2004; 77(Pt 1):19-33. DOI: 10.1348/147608304322874236. View

Stone M, Kokanovic R . "Halfway towards recovery": Rehabilitating the relational self in narratives of postnatal depression. Soc Sci Med. 2016; 163:98-106. DOI: 10.1016/j.socscimed.2016.06.040. View

Seale C, Chaplin R, Lelliott P, Quirk A . Antipsychotic medication, sedation and mental clouding: an observational study of psychiatric consultations. Soc Sci Med. 2007; 65(4):698-711. DOI: 10.1016/j.socscimed.2007.03.047. View

Angell B, Bolden G . Justifying medication decisions in mental health care: Psychiatrists' accounts for treatment recommendations. Soc Sci Med. 2015; 138:44-56. PMC: 4595152. DOI: 10.1016/j.socscimed.2015.04.029. View

Usher K . Taking neuroleptic medications as the treatment for schizophrenia: A phenomenological study. Aust N Z J Ment Health Nurs. 2001; 10(3):145-55. DOI: 10.1046/j.1440-0979.2001.00205.x. View

Davidsen A . Phenomenological Approaches in Psychology and Health Sciences. Qual Res Psychol. 2013; 10(3):318-339. PMC: 3627202. DOI: 10.1080/14780887.2011.608466. View

10.

Seale C, Chaplin R, Lelliott P, Quirk A . Sharing decisions in consultations involving anti-psychotic medication: a qualitative study of psychiatrists' experiences. Soc Sci Med. 2005; 62(11):2861-73. DOI: 10.1016/j.socscimed.2005.11.002. View

11.

Knight F, Kokanovic R, Ridge D, Brophy L, Hill N, Johnston-Ataata K . Supported Decision-Making: The Expectations Held by People With Experience of Mental Illness. Qual Health Res. 2018; 28(6):1002-1015. DOI: 10.1177/1049732318762371. View

12.

Rogers A, Day J, Williams B, Randall F, Wood P, Healy D . The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia. Soc Sci Med. 1998; 47(9):1313-23. DOI: 10.1016/s0277-9536(98)00209-3. View

13.

Bou Khalil R, Richa S . Thyroid adverse effects of psychotropic drugs: a review. Clin Neuropharmacol. 2011; 34(6):248-55. DOI: 10.1097/WNF.0b013e31823429a7. View

14.

Liebert R, Gavey N . "There are always two sides to these things": managing the dilemma of serious adverse effects from SSRIs. Soc Sci Med. 2009; 68(10):1882-91. DOI: 10.1016/j.socscimed.2009.02.047. View

15.

Miller C, Fleischhacker W . Managing antipsychotic-induced acute and chronic akathisia. Drug Saf. 2000; 22(1):73-81. DOI: 10.2165/00002018-200022010-00006. View

16.

Morrison P, Meehan T, Stomski N . Living with antipsychotic medication side-effects: the experience of Australian mental health consumers. Int J Ment Health Nurs. 2014; 24(3):253-61. DOI: 10.1111/inm.12110. View

17.

Parnas J, Handest P . Phenomenology of anomalous self-experience in early schizophrenia. Compr Psychiatry. 2003; 44(2):121-34. DOI: 10.1053/comp.2003.50017. View

18.

Choudhury S, McKinney K, Kirmayer L . "Learning how to deal with feelings differently": Psychotropic medications as vehicles of socialization in adolescence. Soc Sci Med. 2015; 143:311-9. DOI: 10.1016/j.socscimed.2015.02.034. View

19.

Schlosser A, Hoffer L . The psychotropic self/imaginary: subjectivity and psychopharmaceutical use among heroin users with co-occurring mental illness. Cult Med Psychiatry. 2012; 36(1):26-50. DOI: 10.1007/s11013-011-9244-9. View

20.

Zimmermann U, Kraus T, Himmerich H, Schuld A, Pollmacher T . Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res. 2003; 37(3):193-220. DOI: 10.1016/s0022-3956(03)00018-9. View